Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK HAIs (hospital acquired infection): a £1 billion challenge

This article was originally published in Clinica

Executive Summary

This week saw a spate of reports on the UK's hospital acquired infection (HAI) situation. The problem - which already costs the NHS an estimated £1bn ($1.86bn) a year - is being billed as the UK's greatest healthcare challenge, affecting over 100,000 patients and causing some 5,000 deaths. These 2000 figures are said to be "the best estimate available", according to the National Audit Office, in its four-year review of the situation. The NAO report criticises the failure to establish a comprehensive mandatory surveillance scheme, despite plans to improve HAI monitoring (through the NINSS set up in 1996) with orthopaedic surgical site infection, bacteraemia and post-discharge surveillance.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel